These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30218088)

  • 1. Enhanced uptake of gH625 by blood brain barrier compared to liver in vivo: characterization of the mechanism by an in vitro model and implications for delivery.
    Falanga A; Iachetta G; Lombardi L; Perillo E; Lombardi A; Morelli G; Valiante S; Galdiero S
    Sci Rep; 2018 Sep; 8(1):13836. PubMed ID: 30218088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in rats.
    Valiante S; Falanga A; Cigliano L; Iachetta G; Busiello RA; La Marca V; Galdiero M; Lombardi A; Galdiero S
    Int J Nanomedicine; 2015; 10():1885-98. PubMed ID: 25792823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery.
    Iachetta G; Falanga A; Molino Y; Masse M; Jabès F; Mechioukhi Y; Laforgia V; Khrestchatisky M; Galdiero S; Valiante S
    Sci Rep; 2019 Jun; 9(1):9183. PubMed ID: 31235716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells.
    Perillo E; Allard-Vannier E; Falanga A; Stiuso P; Vitiello MT; Galdiero M; Galdiero S; Chourpa I
    Int J Pharm; 2015 Jul; 488(1-2):59-66. PubMed ID: 25891256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery.
    Tarallo R; Accardo A; Falanga A; Guarnieri D; Vitiello G; Netti P; D'Errico G; Morelli G; Galdiero S
    Chemistry; 2011 Nov; 17(45):12659-68. PubMed ID: 21956538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the interaction mechanism with liposomes of gH625-peptide functionalized dendrimers.
    Falanga A; Tarallo R; Carberry T; Galdiero M; Weck M; Galdiero S
    PLoS One; 2014; 9(11):e112128. PubMed ID: 25423477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shuttle-mediated nanoparticle transport across an in vitro brain endothelium under flow conditions.
    Falanga AP; Pitingolo G; Celentano M; Cosentino A; Melone P; Vecchione R; Guarnieri D; Netti PA
    Biotechnol Bioeng; 2017 May; 114(5):1087-1095. PubMed ID: 27861732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimerization in tailoring uptake efficacy of the HSV-1 derived membranotropic peptide gH625.
    Falanga A; Valiante S; Galdiero E; Franci G; Scudiero O; Morelli G; Galdiero S
    Sci Rep; 2017 Aug; 7(1):9434. PubMed ID: 28842580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis and Characterization of Novel Co-Polymers Decorated with Peptides for the Selective Nanoparticle Transport across the Cerebral Endothelium.
    Falanga AP; Melone P; Cagliani R; Borbone N; D'Errico S; Piccialli G; Netti PA; Guarnieri D
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29986452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shuttle-mediated nanoparticle delivery to the blood-brain barrier.
    Guarnieri D; Falanga A; Muscetti O; Tarallo R; Fusco S; Galdiero M; Galdiero S; Netti PA
    Small; 2013 Mar; 9(6):853-62. PubMed ID: 23135878
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Galdiero E; Falanga A; Siciliano A; Maselli V; Guida M; Carotenuto R; Tussellino M; Lombardi L; Benvenuto G; Galdiero S
    Int J Nanomedicine; 2017; 12():2717-2731. PubMed ID: 28435254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines.
    Perillo E; Porto S; Falanga A; Zappavigna S; Stiuso P; Tirino V; Desiderio V; Papaccio G; Galdiero M; Giordano A; Galdiero S; Caraglia M
    Oncotarget; 2016 Jan; 7(4):4077-92. PubMed ID: 26554306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gH625: a milestone in understanding the many roles of membranotropic peptides.
    Galdiero S; Falanga A; Morelli G; Galdiero M
    Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):16-25. PubMed ID: 25305339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
    Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gH625 is a viral derived peptide for effective delivery of intrinsically disordered proteins.
    Smaldone G; Falanga A; Capasso D; Guarnieri D; Correale S; Galdiero M; Netti PA; Zollo M; Galdiero S; Di Gaetano S; Pedone E
    Int J Nanomedicine; 2013; 8():2555-65. PubMed ID: 23901273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro and in vivo study of peptide-functionalized nanoparticles for brain targeting: The importance of selective blood-brain barrier uptake.
    Bode GH; Coué G; Freese C; Pickl KE; Sanchez-Purrà M; Albaiges B; Borrós S; van Winden EC; Tziveleka LA; Sideratou Z; Engbersen JFJ; Singh S; Albrecht K; Groll J; Möller M; Pötgens AJG; Schmitz C; Fröhlich E; Grandfils C; Sinner FM; Kirkpatrick CJ; Steinbusch HWM; Frank HG; Unger RE; Martinez-Martinez P
    Nanomedicine; 2017 Apr; 13(3):1289-1300. PubMed ID: 27884636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
    De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
    J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier.
    Papademetriou I; Vedula E; Charest J; Porter T
    PLoS One; 2018; 13(10):e0205158. PubMed ID: 30300391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage display as a tool to discover blood-brain barrier (BBB)-shuttle peptides: panning against a human BBB cellular model.
    Díaz-Perlas C; Sánchez-Navarro M; Oller-Salvia B; Moreno M; Teixidó M; Giralt E
    Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27486695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.